Fengqiang Cao

430 total citations
10 papers, 352 citations indexed

About

Fengqiang Cao is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Fengqiang Cao has authored 10 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Fengqiang Cao's work include Immunotherapy and Immune Responses (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Fengqiang Cao is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Fengqiang Cao collaborates with scholars based in China, Japan and United States. Fengqiang Cao's co-authors include Guilei Ma, Lanxia Liu, Mengmeng Yan, Yijia Liu, Hongfan Sun, Guanghui Ma, Yufei Xia, Lianpan Dai, Sha Peng and Xiao‐Dong Gao and has published in prestigious journals such as Advanced Materials, ACS Applied Materials & Interfaces and Acta Biomaterialia.

In The Last Decade

Fengqiang Cao

9 papers receiving 350 citations

Peers

Countries citing papers authored by Fengqiang Cao

Since Specialization

Citations

This map shows the geographic impact of Fengqiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengqiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengqiang Cao more than expected).

Fields of papers citing papers by Fengqiang Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengqiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengqiang Cao. The network helps show where Fengqiang Cao may publish in the future.

Co-authorship network of co-authors of Fengqiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengqiang Cao. A scholar is included among the top collaborators of Fengqiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengqiang Cao. Fengqiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Augmenting vaccine efficacy: Tailored immune strategy with alum-stabilized Pickering emulsion 2024 ·Vaccine ·(unknown), Fengqiang Cao, Xiaonan Huang, Sihua Wu, (unknown), To Ngai, Yufei Xia, Guanghui Ma	0
2	Inside-out assembly of viral antigens for the enhanced vaccination 2023 ·Signal Transduction and Targeted Therapy ·Fengqiang Cao, Sha Peng, Yaling An, Kun Xu, Tianyi Zheng, Lianpan Dai, Kenji Ogino, To Ngai, Yufei Xia, Guanghui Ma	11
3	Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel 2022 ·Journal of Biomedical Nanotechnology ·Junge Chen, Fengqiang Cao, Yang Cao, (unknown), Xiurui Zhu, Wanli Xing	16
4	Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization 2022 ·Journal of Visualized Experiments ·Fengqiang Cao, (unknown), (unknown), Jia Ge, Kenji Ogino	2
5	COVID‐19 Vaccines: Particulate Alum via Pickering Emulsion for an Enhanced COVID‐19 Vaccine Adjuvant (Adv. Mater. 40/2020) 2020 ·Advanced Materials ·Sha Peng, Fengqiang Cao, Yufei Xia, Xiao‐Dong Gao, Lianpan Dai, Jinghua Yan, Guanghui Ma	1
6	Particulate Alum via Pickering Emulsion for an Enhanced COVID‐19 Vaccine Adjuvant 2020 ·Advanced Materials ·Sha Peng, Fengqiang Cao, Yufei Xia, Xiao‐Dong Gao, Lianpan Dai, Jinghua Yan, Guanghui Ma	98
7	Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy 2018 ·Biomaterials Science ·Fengqiang Cao, (unknown), (unknown), (unknown), Lu Li, (unknown), Chaohua Zhang, Hongfan Sun, Deling Kong, (unknown)	14
8	Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination 2018 ·Acta Biomaterialia ·Xiaoli Wang, Fengqiang Cao, Mengmeng Yan, Yijia Liu, (unknown), Hongfan Sun, Guilei Ma	42
9	Photothermally Controlled MHC Class I Restricted CD8⁺ T‐Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy 2018 ·Advanced Healthcare Materials ·Fengqiang Cao, Mengmeng Yan, Yijia Liu, Lanxia Liu, Guilei Ma	67
10	Hyaluronic Acid-Modified Cationic Lipid–PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses 2016 ·ACS Applied Materials & Interfaces ·Lanxia Liu, Fengqiang Cao, Xiaoxuan Liu, Hai Wang, Chao Zhang, Hongfan Sun, Chun Wang, Xigang Leng, Cunxian Song, Deling Kong, Guilei Ma	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact